HEART FAILURE ADVOCACY: THE STATE OF HF SERVICES AND GDMT PROVINCIAL COVERAGE IN CANADA/ JOINT PRESENTATION OF THE HEART AND STROKE FOUNDATION AND THE CCS HF WORKING GROUP
234 - HEART FAILURE ADVOCACY: PROVINCIAL DIFFERENCES IN GDMT COVERAGE - MOVING TOWARDS A UNIVERSAL APPROACH
Friday, October 28, 2022
11:00 AM – 11:20 AM EDT
Location: Room 215
Target Audience: Heart Failure Specialists, General: All cardiovascular (clinical and research) health professionals, Allied Health
Cardiologist St. Paul's Hospital, University of British Columbia University of British Columbia Vancouver, British Columbia, Canada
Learning Objectives:
At the conclusion of this session, participants will be able to:
describe the provincial differences in the coverage of GDMT for patients with HFREF; and
appreciate the importance of using a universal approach for the inclusion of GDMT in the provincial drug formularies.
It is well established that GDMT for patients with HFREF plays a significant role in reducing mortality and heart failure hospitalizations. Within Canada, there are differences in the inclusion of GDMT in the provincial drug formularies. In this session, the CCS Advocacy Committee and the CCS Heart Failure Working Group will describe the provincial differences in accessing GDMT and explore strategies and opportunities to advocate for a more universal approach for formulary approval.
